Thalia Therapeutics PLC
Last updated September 28, 2026
Organization details
- Legal name
- Thalia Therapeutics PLC
- Former names
- N4 Pharma PLC Onzima Ventures PLC Ultima Networks PLC
- Ownership
- Public
- Status
- Active
- SIC code
- 62090 - Other information technology service activities
- Year founded
- 1979
- Jurisdiction of incorporation
- England and Wales
- Headquarters city
- London
- Headquarters country
- United Kingdom
- Fiscal year end
- December
Identifiers
- UK company number
- 01435584
Board of directors
-
Christopher Jonathan Britten · DirectorSince 2019
-
David Alastair Maclaughlin, Smith · DirectorSince 2025
-
David Horn, Solomon · DirectorSince 2026
-
Edward James Norman Wardle · DirectorSince 2025
-
Luke Sebastian Cairns · DirectorSince 2015
-
Michael Gavin, Palfreyman · DirectorSince 2024
Former directors
-
Anthony Philip Klein · Director2008 – 2015
-
David, Templeton · Director2017 – 2025
-
Gavin John Burnell · Director2015 – 2017
-
Humayun Akhter, Mughal · Director1998 – 2017
-
John Chiplin · Director2019 – 2023
-
Nigel James Theobald · Director2017 – 2026
-
Paul Charlton Titley · Director2017 – 2019
Board connections
2 of this board's directors also sit on 1 other board.
- via David Alastair Maclaughlin, Smith and Edward James Norman Wardle
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.